Clinical Trial

RealTime eClinical Solutions Honors Research Organizations as “Guiding Stars of Clinical Trials” in Celebration of Clinical Trials Day 2025

SAN ANTONIO, May 20, 2025 /PRNewswire/ -- In celebration of Clinical Trials Day 2025, RealTime eClinical Solutions, a leading provider…

7 months ago

Trial Library Works with Texas Oncology to Enhance Patient Clinical Trial Navigation

SAN FRANCISCO, May 20, 2025 /PRNewswire/ -- Trial Library, a technology company focused on equitable access to oncology clinical trials,…

7 months ago

From Retina Scans to Cancer Trials, AI Is Taking Over the Exam Room

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 20, 2025 /PRNewswire/ -- Equity Insider…

7 months ago

New Study Published on the Safety and Feasibility of Pulsed Electric Field Ablation for Early-Stage Non-Small Cell Lung Cancer Prior to Surgical Resection

Innovative technology offers promising non-thermal approach to soft tissue ablation without compromising sensitive structures. REDWOOD CITY, Calif., May 20, 2025…

7 months ago

Hemostemix Presents at TERMIS 2025, Freiburg, Germany

Freiburg, Germany--(Newsfile Corp. - May 20, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF), a leading Phase III clinical-stage biotechnology…

7 months ago

UCB and Domino Data Lab Collaborate to Modernize Statistical Computing Environment in Life Sciences

Collaboration Blends Advanced Cloud Technologies, Open-Source Collaboration, and Data Science Integration to support UCB's development pipeline BRUSSELS and SAN FRANCISCO, May…

7 months ago

eCOA Solutions Market worth US$4.78 billion by 2030 with 16.1% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., May 19, 2025 /PRNewswire/ -- The global eCOA solution market, valued at US$1.94 billion in 2024, is forecasted…

7 months ago

Vitalograph and Thorasys Forge Strategic Partnership to Expand Respiratory Diagnostics with Launch of Tremoflo® C2 Oscillometer

SAN FRANCISCO, May 19, 2025 /PRNewswire/ -- At the American Thoracic Society (ATS) Annual Conference, Vitalograph and Thorasys announced a…

7 months ago

vTv Therapeutics Appoints Michael Tung, M.D., MBA, to Chief Financial Officer as Company Reinitiates Phase 3 Trial of Oral T1D Adjunctive Therapy to Insulin

HIGH POINT, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company, today announced…

7 months ago

Arbor Biotechnologies Appoints Don Haut, Ph.D., as Chief Business Officer

Seasoned biopharma executive brings more than twenty years of business development, strategy, and operational expertise to Arbor’s leadership teamCAMBRIDGE, Mass.,…

7 months ago